Changes in tyrosine hydroxylase mRNA expression in the rat locus coeruleus following acute or chronic treatment with valproic acid

Neuropsychopharmacology

Volumn 22, Issue 1, 2000, Pages 27-35

  Sands, Scott Alan ^a   Guerra, Victoria ^a   Morilak, David Andrew ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Antimanic; In situ hybridization; Locus coeruleus; Norepinephrine; Tyrosine hydroxylase; Valproic acid

Indexed keywords

ALPHA 2A ADRENERGIC RECEPTOR; AUTORECEPTOR; MESSENGER RNA; NORADRENALIN; TYROSINE 3 MONOOXYGENASE; VALPROIC ACID;

AFFECTIVE NEUROSIS; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; GENE EXPRESSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMOBILIZATION STRESS; IN SITU HYBRIDIZATION; LOCUS CERULEUS; MALE; MANIC DEPRESSIVE PSYCHOSIS; NONHUMAN; NORADRENERGIC SYSTEM; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; CARRIER PROTEINS; DRUG ADMINISTRATION SCHEDULE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; LOCUS COERULEUS; MALE; NOREPINEPHRINE; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-2; RESTRAINT, PHYSICAL; RNA, MESSENGER; STRESS, PSYCHOLOGICAL; SYMPORTERS; TRANSCRIPTION, GENETIC; TYROSINE 3-MONOOXYGENASE; VALPROIC ACID;

EID: 0033990167     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(99)00072-X     Document Type: Article

References (44)

1. Aston-Jones G., Chiang C., Alexinsky T. Discharge of noradrenergic locus coeruleus neurons in behaving rats and monkeys suggests a role in vigilance. Prog Brain Res. 88:1991;501-520.
2. Baf M.H., Subhash M.N., Lakshmana K.M., Rao B.S. Sodium valproate induced alterations in monoamine levels in different regions of the rat brain. Neurochem Int. 24:1994;67-72.
3. Bowden C.L., Brugger A.M., Swann A.C., Calabrese J.R., Janicak P.G., Petty F., Dilsaver S.C., Davis J.M., Rush A.J., Small J.G., Garza-Trevino E.S., Risch S.C., Goodnick P.J., Morris D.D. Efficacy of divalproex vs lithium and placebo in the treatment of mania. JAMA. 271:1994;918-924.
4. Brady L.S., Whitfield H.J., Fox R.J., Gold P.W., Herkenham M. Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. J Clin Invest. 87:1991;831-837.
5. Cambi F., Fung B., Chikaraishi D. 5' flanking DNA sequences direct cell-specific expression of rat tyrosine hydroxylase. J Neurochem. 53:1989;1656-1659.
6. Charney D.S., Woods S.W., Nagy L.M., Southwick S.M., Krystal J.H., Heninger G.R. Noradrenergic function in panic disorder. J Clin Psychiat. 51(Suppl. A):1990;5-11.
7. Chen G., Manji H.K., Hawver D.B., Wright C.B., Potter W.Z. Chronic sodium valproate selectively decreases protein kinase C α and ε in vitro. J Neurochem. 63:1994;2361-2364.
8. Chen G., Yuan P., Hawver D.B., Potter W.Z., Manji H.K. Increase in AP-1 transcription factor DNA binding activity by valproic acid. Neuropsychopharmacology. 16:1997;238-245.
9. Chen G., Yuan P.-X., Jiang Y.-M., Huang L.-D., Manji H.K. Valproate robustly enhances AP-1 mediated gene expression. Mol Brain Res. 64:1999;52-58.
10. Delbende C., Contesse V., Mocaer E., Kamoun A., Vaudry H. The novel antidepressant, tianeptine, reduces stress-evoked stimulation of the hypothalamo-pituitary-adrenal axis. Eur. J Pharmacol. 202:1991;391-396.
11. Dreyfus C.F., Friedman W.J., Markey K.A., Black I.B. Depolarizing stimuli increase tyrosine hydroxylase in the mouse locus coeruleus in culture. Brain Res. 379:1986;216-222.
12. Elias A.N., Gwinup G., Valenta L.J. Effects of valproic acid, naloxone and hydrocortisone in Nelson's syndrome and Cushing's disease. Clin Endocrinol. 15:1981;151-154.
13. Foote S.L., Bloom F.E., Aston-Jones G. Nucleus locus coeruleus. New evidence of anatomical and physiological specificity Physiol Rev. 63:1983;844-914.
14. Fritz J.D., Jayanthi L.D., Thoreson M.A., Blakely R.D. Cloning and chromosomal mapping of the murine norepinephrine transporter. J Neurochem. 70:1998;2241-2251.
15. Gibson A., Hart S.L., Patel S. Effects of 6-hydroxydopamine-induced lesions of the paraventricular nucleus, and of prazosin, on the corticosterone response to restraint in rats. Neuropharmacol. 25:1986;257-260.
16. Icard-Liepkalns C., Faucon Biguet N., Vyas S., Robert J.J., Sassone-Corsi P., Mallet J. AP-1 complex and c-fos transcription are involved in TPA provoked and trans-synaptic inductions of the tyrosine hydroxylase gene. insights into long-term regulatory mechanisms J Neurosci Res. 32:1992;290-298.
17. Jones M.T., Gillham B., Altaher A.R.H., Nicholson S.A., Campbell E.A., Watts S.M., Thody A. Clinical and experimental studies on the role of GABA in the regulation of ACTH secretion. A review Psychoneuroendocrinol. 9:1984;107-123.
18. 1-adrenergic receptors in the secretion of hypothalamic corticotropin-releasing hormone during stress. Neuroendocrinol. 56:1992;153-160.
19. Kofman O., Levin U., Alpert C. Lithium attenuates hypokinesia induced by immobilization stress in rats. Prog Neuro-Psychopharmacol Biol Psychiat. 19:1995;1081-1090.
20. Lenox R.H., McNamara R.K., Watterson J.M., Watson D.G. Myristoylated alanine-rich C kinase substrate (MARCKS). a molecular target for the therapeutic action of mood stabilizers in the brain J Clin Psychiatry. 57(suppl 13):1996;23-31.
21. Loscher W. Effects of the antiepileptic drug valproate on metabolism and function of inhibitory and excitatory amino acids in the brain. Neurochem Res. 18:1993;485-502.
22. Loscher W., Fisher J.E., Nau H., Honack D. Valproic acid in amygdala-kindled rats. Alterations in anticonvulsant efficacy, adverse effects and drug and metabolite levels in various brain regions during chronic treatment J Pharmacol Exper Therap. 250:1989;1067-1078.
23. Manji H.K., Chen G., Hsiao J.K., Risby E.D., Masana M.I., Potter W.Z. Regulation of signal transduction pathways by mood-stabilizing agents. Implications for the delayed onset of therapeutic efficacy J Clin Psychiat. 57(Suppl.13):1996;34-46.
24. Manji H.K., Lenox R.H. Long-term action of lithium. a role for transcriptional and posttranscriptional factors regulated by protein kinase C Synapse. 16:1994;11-28.
25. Mann C.D., Vu T.B., Hrdina P.D. Protein kinase C in rat brain cortex and hippocampus. effect of repeated administration of fluoxetine and desipramine Br J Pharmacol. 115:1995;595-600.
26. McMahon A., Kvetnansky R., Fukuhara K., Weise V.K., Kopin I.J., Sabban E.L. Regulation of tyrosine hydroxylase and dopamine β-hydroxylase mRNA levels in rat adrenals by a single and repeated immobilization stress. J Neurochem. 58:1992;2124-2130.
27. Melia K.R., Rasmussen K., Terwilliger R.Z., Haycock J.W., Nestler E.J., Duman R.S. Coordinate regulation of the cyclic AMP system with firing rate and expression of tyrosine hydroxylase in the rat locus coeruleus. Effect of chronic stress and drug treatments J Neurochem. 58:1992;494-502.
28. Moore R.Y., Bloom F.E. Central catecholamine neuron system. Anatomy and physiology of the norepinephrine and epinephrine systems Ann Rev Neurosci. 2:1979;113-168.
29. Morilak DA, Blincoe S, Sands SA (1998): Changes in gene expression in the rat locus coeruleus following acute or chronic desipramine or valproate. Soc Neurosci Abs 24: 1988.
30. Nestler E.J., McMahon A., Sabban E.L., Tallman J.F., Duman R.S. Chronic antidepressant administration decreases the expression of tyrosine hydroxylase in the rat locus coeruleus. Proc Natl Acad Sci USA. 87:1990;7522-7526.
31. Olpe H.R., Steinmann M.W., Pozza M.F., Brugger F., Schmutz M. Valproate enhances GABA-A mediated inhibition of locus coeruleus neurones in vitro. N-S Arch Pharmacol. 338:1988;655-657.
32. Osmanovic S.S., Shefner S.A. γ-aminobutyric acid responses in rat locus coeruleus neurons in vitro. a current-clamp and voltage-clamp study J Physiol. 421:1990;151-170.
33. Paxinos G, Watson C (1986) The Rat Brain in Stereotaxic Coordinates, 2nd Edition. Academic Press, Academic Press.
34. Petraglia F., Bakalakis S., Facchinetti F., Volpe A., Muller E.E., Genazzani A.R. Effects of sodium valproate and diazepam on beta-endorphin, beta-lipotropin and cortisol secretion induced by hypoglycemic stress in humans. Neuroendocrinol. 44:1986;320-325.
35. Plotsky P.M. Facilitation of immunoreactive corticotropin-releasing factor secretion into the hypophysial-portal circulation after activation of catecholaminergic pathways or central norepinephrine injection. Endocrinol. 121:1987;924-930.
36. Puumala T., Riekkinen P., Sirvio J. Modulation of vigilance and behavioral activation by alpha-1 adrenoceptors in the rat. Pharm Biochem Behav. 56:1997;705-712.
37. Schatzberg A.F., Schildkraut J.J. Recent studies on norepinephrine systems in mood disorders. Bloom F.E., Kupfer D.J. Psychopharmacology. The Fourth Generation of Progress:1995;911-920 Ltd., New York, Raven Press.
38. Schildkraut J.J. The catecholamine hypothesis of affective disorders. a review of supporting evidence Am J Psychiatry. 122:1965;509-522.
39. Siegel J.M., Rogawski M.A. A function for REM sleep. regulation of noradrenergic receptor sensitivity Brain Res Revs. 13:1988;213-233.
40. Szafarczyk A., Malaval F., Laurent A., Gibaud R., Assenmacher I. Further evidence for a central stimulatory action of catecholamines on adrenocorticotropin release in the rat. Endocrinol. 121:1987;883-892.
41. Van den Berg R.J., Kok P., Voskuyl R.A. Valproate and sodium currents in cultured hippocampal neurons. Exp Brain Res. 93:1993;279-287.
42. Vyas S., Faucon Biguet N., Mallet J. Transcriptional and post-transcriptional regulation of tyrosine hydroxylase gene by protein kinase C. EMBO J. 9:1990;3707-3712.
43. 2D-adrenergic receptor gene in vascular smooth muscle. Am J Physiol. 273:1997;H85-H95.
44. Yuan P.X., Chen G., Granneman J.G., Manji H.K. Increase in the expression of AP-1 regulated genes in brain by the mood stabilizing agents lithium and valproic acid. Soc Neurosci Abs. 27:1997;2045.